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INTRODUCTION
The Long-Evans Cinnamon (LEC) rat has abnor-
malities in copper excretion in the liver and T-cell
maturation in the thymus (1, 2). Excess copper in-
duces toxic hepatitis while liver and kidney tumors
develop spontaneously in LEC rats (3, 4). A recent
our report indicates that inflammatory bowel dis-
ease- like colitis develops in the LEC strain as a con-
sequence of regulatory T-cell dysfunction making
this strain is susceptible to N -methyl-N -nitrosourea
(MNU) and azoxymethane (AOM)-induced colon
carcinogenesis (5). In contrast, our previous studies
demonstrated that LEC rats are resistant to N-dieth-
ylnitrosamine (DEN), MNU and to N -nitrosobis
(2-hydroxypropyl)amine(BHP)-induced lung car-
cinogenesis, and N -butyl-N -(hydroxybutyl) nitro-
samine(BBN)-induced bladder carcinogenesis in
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our studies (6, 7).
Prenatal and neonatal administrations of N -ethyl-
N -nitrosourea (ENU) induce brain and trigeminal
nerve tumors (8). Intracranial schwannomas in
rats originate in trigeminal nerve, but in humans,
trigeminal nerve is the second most frequent site
next to the vestibular nerve (9). ENU is an alkylating
agent and it was demonstrated that the exposure to
ENU causes O6-alkylguanine formation in DNA
(10), and the adduct is removed by repair enzymes
such as O6-methylguanine-DNA methyltransferase
(MGMT)(11, 12).
In the present study, we investigated the ENU-in-
duced transplacental carcinogenesis and the mecha-
nisms of cancer susceptibilities in the three strains
of rats.
MATERIALS AND METHODS
Animals
Inbred LEC/Tj and LEA/Tj rats were bred in the
Institute for Animal Experimentation of the Univer-
sity of Tokushima, Tokushima, in specific pathogen-
free conditions. F344/DuCrj rats were purchased
from Charles River Japan, Inc., Kanagawa, Japan.
Animals were housed three in a plastic cage with
sterilized woodchips for bedding in an air-condi-
tioned room at 232and 5510% humidity with
a 12 h light/dark cycle. They were fed a pellet diet
(Oriental Yeast Co., Tokyo, Japan) and received tap
water ad libitum. Experiments were conducted ac-
cording to the Guideline for the Care and Use of
Laboratory Animals of the University of Tokushima
Graduate School, and all experimental protocols
were approved by the Animal Committee.
Carcinogenicity study
Male and female rats (n=21) of LEC, LEA and
F344 strains were used. Pregnant rats were given
s.c. injections of 60 mg/kg ENU (Sigma Chemical
Co., St. Louis, MO.) dissolved in 0.1 M citrate buffer
(pH 6.0) on the 17th day after conception. Vaginal
smears were examined every morning to confirm
the conception. Body weight was monitored every
other week, and all surviving animals were killed at
30 weeks of age under carbon oxide narcosis. The
brain, spinal cord, lungs, kidneys, soft tissues and
bone were fixed in 10% buffered formalin, embedded
in paraffin. For histological examination, sections
were stained with hematoxylin and eosin.
Semiquantitative RT-PCR
Livers from male F344, LEA, and LEC rats (9
weeks old for MT1a and MT2 mRNA, 21 weeks old
for MGMT mRNA) were stabilized with RNAlater
(Ambion) for over night at 4and then total RNAs
were isolated using an RNeasyMini Kit (QIAGEN).
By using 2 μg (for MT1a and MT2 mRNA) or 5 μg
(for MGMT mRNA) aliquots, cDNAs were synthe-
sized with SuperScript II reverse transcriptase and
random hexamers (Invitrogen). Reactions were con-
ducted at 42for 60 min, after the increase of tem-
perature to 72for 15 min. The total cDNAs were
then amplified by PCR following a thermocycling
program at 94for 10 min for initial denaturation,
94for 30 s, 55for 1 min, and 72for 1 min for
amplification, and a final extension at 72for 10
min for MT1a, MT2, and β -actin or 95for 5 min
for initial denaturation, 95for 30 s, 50for 3 min,
and 72for 3 min for amplification, and a final ex-
tension at 72for 10 min for MGMT, respectively.
The numbers of amplification cycles were as fol-
lows : MT1a and MT2, 25 cycles ; MGMT, 45 cy-
cles ; and β -actin, 23 cycles. PCR reactions were
visualized by ethidium bromide after separating by
1.5% agarose gel electrophoresis. Sequences of
primers were : rMt1a-F 5’ -AACTGCTCCTGCTCC-
ACC-3’, rMt1a-R 5’-TCAGGCACAGCACGTGCA-3’,
rMt2-F 5’ -AACTGCTCCTGTGCCACAG-3’, rMt2-
R 5’-CTCTTTGCAGATGCAGCC-3’, rMGMT3-F 5’-
AGCCTGGCTGGAAGCCTA-3’, rMGMT3-R 5’ AT-
TGCTCCTCATCGCTCC 3’, β -actin-F 5’ -TACAAT-
GAGCTGCGTGTGG-3’, and β -actin-R 5’ -AGATG-
GGCACAGTGTGGG-3’.
Western blot analysis
Livers from male F344, LEA, and LEC rats (9-
weeks old) were lysed with radioimmunoprecipita-
tion buffer [50 mM Tris-HCl (pH 7.5), 150 mM
NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1%
SDS, 1 mM DTT, and 1 mM phenylmethylsulfonyl
fluoride] and the protein concentrations of the sam-
ples were quantified using a DC Protein Assay Kit
(Bio-Rad). Next, aliquots (25 μg protein) were sub-
jected to SDS-PAGE (12% gel) and transferred to
polyvinylidene difluoride membranes. Mouse mono-
clonal antibody against metallothionein (Clone
UC1MT, QED Bioscience) and rabbit polyclonal
antibody against actin (Sigma) were used as the pri-
mary antibodies. Anti-metallothionein recognizes
both MT1 and MT2. Goat anti-mouse IgG -horse-
radish peroxidase (American Qualex) and Goat
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anti-rabbit IgG-horseradish peroxidase (Invitrogen)
were employed as the secondary antibodies. The di-
lution rates were as follows : anti-metallothionein
(1 : 1,000), anti-actin (1 : 8,000), anti-mouse IgG-
horseradish peroxidase (1 : 50,000), and anti-rabbit
IgG-horseradish peroxidase (1 : 150,000). An Im-
mobilon Western horseradish peroxidase substrate
(Millipore) was applied to detect the signals.
Statistical analyses
The incidences of tumors were analyzed by
Fisher’s exact probability test.
RESULTS
ENU-induced carcinogenesis
Six of male and ten of female LEC rats died of
copper-mediated hepatic injury by 21 weeks old and
17 weeks old, respectively. Table 1 shows the inci-
dences of tumors in three strains of rats. The cen-
tral and peripheral nervous system and the lung
were the major target organs of ENU in LEA and
F344 rats. There were no significant sex differences
in all neoplasms. In contrast, no nervous system and
lung tumors developed in male and female LEC rats,
the difference being significant from LEA and F344
rats. Soft tissue and bone tumors developed in LEA
and F344 rats at low incidences, but no tumors were
observed in LEC rats. Histologically, brain tumors
were gliomas, and peripheral nervous system tu-
mors were malignant schwannomas (Fig. 1). All
lung tumors were adenomas.
Expression of MT and MGMT
In LEC strain, MT1a and MT2 mRNA levels in
the liver were clearly higher than those in other
strains (Fig. 2A). Western blot analysis revealed that
protein level of MT (MT1 plus MT2) in LEC strain
was extremely higher than that in other strains (Fig.
2B). Like the result of MT, MGMT mRNA level in
LEC strain was clearly higher than that in other
two strains (Fig. 2C). We tried Western blotting of
MGMT using anti-mouse antibody, but the suitable
Table 1. Incidences of N -ethyl -N -nitrosourea- induced tumors in male and female LEC, F344 and LEA rats.
Strain
Effective
no. of
rats
Tumors
Brain and
spinal cord
Trigeminal and
spinal nerve Lung Kidney
Soft tissue
and bone
Male
LEC 15a 0c,e 0d,e 0c 0 0
LEA 21 9(43%) 14(67%) 12(57%) 0 4(19%)
F344 21 7(33%) 8(38%) 5(24%) 0 1(5%)
Female
LEC 11b 0e 0c 0 1(9%) 0
LEA 21 4(19%) 11(52%) 4(19%) 2(10%) 3(14%)
F344 21 8(38%) 6(29%) 0 0 1(5%)
aSix rats died of hepatic injury between 17 and 21 weeks old.
bTen rats died of hepatic injury between 15 and 17 weeks old.
c,dSignificantly different from LEA rat at cP0.01, dP0.001 by Fischer’s exact probability test.
eSignificantly different from F344 rat at P0.05 by Fischer’s exact probability test.
A B
C D
Fig. 1. Gross and histological appearance of the tumors.
A, Cerebral and trigeminal nerve tumors (F344, male). B, Cere-
bral glioma (F344, male). C, Trigeminal schwannoma (LEA,
male). D, Malignant schwannoma of the spinal nerve (F344, fe-
male). Bar, 100 μm.
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antibodies that react to rat MGMT protein were not
obtained at present. Although data was not shown,
we examined the expression level of MGMT mRNA
in the brain, but no expression was observed in all
strains.
DISCUSSION
We first described that the LEC rat is an entirely
resistant strain to ENU-induced transplacental car-
cinogenesis of the nervous system and lung. Strain
difference and genetic susceptibilities to ENU-in-
duced neural tumors in rats have been investigated
(13-15). Indeed, it is known that BDIV is a resistant
strain while BDIX and BDVI are susceptible strains
(13). Wistar-Furth rats are more resistant than Long-
Evans rats and males are more susceptible than fe-
males (14), whereas our data showed no sex differ-
ences in the incidences of neuronal tumors. An anal-
buminemic rat is a susceptible strain than control
Sprague-Dawley rats, although O6-ethylguanine for-
mation and elimination in the fetal brain are not dif-
ferent in both strains (15). Recently, multiple tumor
susceptibility/resistance loci of ENU-induced ma-
lignant schwannomas in BD strains are mapped on
chromosome 10 et al. (16, 17).
It has been demonstrated that MGMT exerts a
protective effect on nitrosamine-induced liver and
lung carcinogenesis in the studies using knock-
out and transgenic mouse models (18-20). Metal-
lothionein (MT) is a cysteine rich metal-binding
protein that is inducible by endogenous and exoge-
nous stimuli and has protective roles in apoptosis
and drug resistance (21). It has been pointed out
that MT exerts a protective effect on skin, kidney
and bladder carcinogenesis in the studies using MT-
I/II deficient mice (22-24). We showed that MGMT
and MT in the LEC rat liver were higher than those
in LEA and F344 strains by semiquantitative RT-
PCR and Western blotting. Data on knockout/trans-
genic models suggest that the overexpression of
both MGMT and MT exerts an important role in
the low susceptibility of LEC rats to ENU-induced
transplacental carcinogenesis.
Oligonucleotide microarray analyses using Rat
oligomicroarray kit (Agilent Technologies) were
performed. Accordingly, gene expression of MT and
MGMT in the liver of 21-week-old male LEC rats
was96.5 and3.5 times those in LEA and F344
rats, respectively. These data are consistent with a
previous report (25).
Taken together, our data suggest that the over-
expression of both MT and MGMT would exert an
additive protective effect on ENU-induced carcino-
genesis in LEC rats. Further experiments are nec-
essary to elucidate the role of these and other genes
participating cancer susceptibility in LEC rats.
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